Therapy education for patients receiving oral anti-coagulants vitamin K antagonists;Éducation thérapeutique des patients traités par anticoagulants oraux antivitamines K

Presse Medicale

Volumn 38, Issue 12, 2009, Pages 1780-1787

  Satger, Bernadette ^a,b   Blaise, Sophie ^a,b   Fontaine, Michèle ^a,b   Yver, Jacqueline ^a,b   Allenet, Benoît ^b,c   Baudrant, Magali ^b,c   Pernod, Gilles ^a,b   Bosson, Jean Luc ^c  

^a Réseau ville hôpital Granted Grenoble   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c LABORATOIRE TIMC IMAG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP;

ARTICLE; BLEEDING; CHEMICALLY INDUCED DISORDER; COOPERATION; DOCTOR PATIENT RELATION; DOSE RESPONSE; DRUG ANTAGONISM; HUMAN; INTERDISCIPLINARY COMMUNICATION; METHODOLOGY; NURSE PATIENT RELATIONSHIP; ORAL DRUG ADMINISTRATION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SOCIAL SUPPORT; THROMBOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTICOAGULANTS; COOPERATIVE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMORRHAGE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MEDICATION ADHERENCE; NURSE-PATIENT RELATIONS; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SOCIAL SUPPORT; THROMBOSIS; TREATMENT OUTCOME; VITAMIN K;

EID: 73449129024     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.07.019     Document Type: Short Survey

References (17)

1. Pouyanne P., Haramburu F., Imbs J.L., Bégaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000, 320:1036.
2. Palaretti G., Leali N., Coccheri S., Poggi N., Manotti C., D'Angelo A., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996, 348:423-428.
3. Michel P., Quenon J., Djihoud A., Tricaud-Vialle S., de Sarasqueta A., Domecq S. Les événements indésirables graves liés aux soins observés dans les établissements de santé: premiers résultats d'une étude nationale (Enquête ENEIS). DRESS Etudes et Résultats 2005, 398:1-16.
4. Levesque H. Risques hémorragiques des anti-vitamines K au cours de la maladie thrombo-embolique veineuse. J Mal Vasc 2002, 27:129-136.
5. Gruel Y., Maakaroun A. Accidents des anticoagulants. La Revue du Praticien 2002, 52:1929-1935.
6. Linkins L.-A., Chol P., Douketis J. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. A meta-analysis. Ann Intern Med 2003, 139:893-900.
7. AFSSAPS. Dossiers thématiques: Traitements par antivitamine K. Mise à jour 24 avril 2009. http://www.afssaps.fr/.
8. Bourget S., Baudrant M., Allenet B., Calop J. Oral anticoagulants: a littérature review of herb-drug interactions or food-drug interactions. J Pharm Belg 2007, 62:69-75.
9. Palareti G., Legnani C., Guazzaloca G., Lelia V., Cosmi B., Lunghi B., et al. Ad hoc Study group of the italian federation of anticoagulation clinics. Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol 2005, 129:72-78.
10. Wofford J.L., Wells M.D., Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Services Research 2008, 8:40.
11. Khan T.I., Kamali F., Kesteven P., Avery P., Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol 2004, 126:557-564.
12. Beyth R.J., Quinn L., Landefeld C.S. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med 2000, 133:687-695.
13. Laporte S., Quenet S., Buchmüller-Cordier A., Reynaud J., Tardy-Poncet B., Thirion C., et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 2003, 89:458-467.
14. Leger S., Allenet B., Calop J., Bosson J.L. Therapeutic Education of patients receiving anticoagulants for thromboembolic venous disease: description of the Educ'AVK program. J Mal Vasc 2004, 29:145-151.
15. Pernod G., Labarère J., Yver J., Satger B., Allenet B., Berremili T., et al. EDUC'AVK: Reduction of oral anticoagulant-related adverse events after patient education: A prospective multicenter open randomized study. J Gen Intern Med 2008, 23:1441-1446.
16. HAS. Guide méthodologique. Structuration d'un programme d'éducation thérapeutique du patient dans le champ des maladies chroniques. Juin 2007. http://www.has-sante.fr/.
17. Gazolo C., Tremey B., Pernod G., Sié P. Surdosage asymptomatique en antivitamines K. STV 2008, 20:56-68. (N° spécial).